WallStreetZenWallStreetZen

NASDAQ: CRSP
Crispr Therapeutics Ag Stock Forecast, Predictions & Price Target

Analyst price target for CRSP

Based on 14 analysts offering 12 month price targets for Crispr Therapeutics Ag.
Min Forecast
$43.00-8.76%
Avg Forecast
$73.71+56.41%
Max Forecast
$110.00+133.4%

Should I buy or sell CRSP stock?

Based on 14 analysts offering ratings for Crispr Therapeutics Ag.
Buy
Strong Buy
5 analysts 35.71%
Buy
4 analysts 28.57%
Hold
4 analysts 28.57%
Sell
0 analysts 0%
Strong Sell
1 analysts 7.14%

Be the first to know when Wall Street analysts revise their CRSP stock forecasts and price targets.

CRSP stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Mizuho
Bottom 13%
13
Strong BuyInitiates Coverage On$82.00+73.99%2023-09-27
Citigroup
Bottom 5%
5
Strong BuyUpgrades$70.00+48.53%2023-08-18
Morgan Stanley
Top 7%
94
Strong SellMaintains$43.00-8.76%2023-08-14
Oppenheimer
Top 5%
96
BuyReiterates$102.00+116.42%2023-08-10
Credit Suisse
Bottom 23%
23
HoldMaintains$63.00+33.67%2023-08-08
EF Hutton
Bottom 2%
2
Strong BuyReiterates$75.00+59.13%2023-08-08
Needham
Bottom 7%
7
BuyReiterates$88.00+86.72%2023-08-08
Chardan Capital
Top 8%
93
Strong BuyMaintains$110.00+133.40%2023-08-08
JMP Securities
Bottom 6%
6
BuyReiterates$74.00+57.01%2023-07-25
Barclays
Top 23%
78
HoldMaintains$64.00+35.79%2023-06-01

1 of 2

Forecast return on equity

Is CRSP forecast to generate an efficient return?
Company
N/A
Industry
0.6%
Market
28.73%

Forecast return on assets

Is CRSP forecast to generate an efficient return on assets?
Company
N/A
Industry
-0.11%

CRSP revenue growth forecast

How is CRSP forecast to perform vs Biotechnology companies and vs the US market?
Company
109.39%
Industry
34.63%
Market
8.12%
CRSP's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CRSP's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CRSP vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CRSP$47.13$73.71+56.41%Buy
DNA$1.78$1.25-29.78%Strong Sell
INSM$25.90$46.33+78.89%Strong Buy
FOLD$12.88$16.00+24.22%Buy
IMGN$15.40$23.00+49.35%Strong Buy

Crispr Therapeutics Ag Stock Forecast FAQ

Is Crispr Therapeutics Ag Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 14 Wall Street analysts covering (NASDAQ: CRSP) stock is to Buy CRSP stock.

Out of 14 analysts, 5 (35.71%) are recommending CRSP as a Strong Buy, 4 (28.57%) are recommending CRSP as a Buy, 4 (28.57%) are recommending CRSP as a Hold, 0 (0%) are recommending CRSP as a Sell, and 1 (7.14%) are recommending CRSP as a Strong Sell.

If you're new to stock investing, here's how to buy Crispr Therapeutics Ag stock.

What is CRSP's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: CRSP) forecast ROE is N/A, which is considered weak.

What is CRSP's Price Target?

According to 14 Wall Street analysts that have issued a 1 year CRSP price target, the average CRSP price target is $73.71, with the highest CRSP stock price forecast at $110.00 and the lowest CRSP stock price forecast at $43.00.

On average, Wall Street analysts predict that Crispr Therapeutics Ag's share price could reach $73.71 by Sep 27, 2024. The average Crispr Therapeutics Ag stock price prediction forecasts a potential upside of 56.41% from the current CRSP share price of $47.13.

What is CRSP's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: CRSP) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of -0.11%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.